暂无数据
代码股票名称
最新价涨跌额涨跌幅成交量成交额今开昨收最高最低总市值流通市值总股本流通股本5日涨跌幅10日涨跌幅20日涨跌幅60日涨跌幅120日涨跌幅250日涨跌幅年初至今涨跌幅股息率TTM换手率市盈率TTM市盈率(静)振幅所属行业
暂无数据
Cartesian Therapeutics将参加在纳斯达克举行的H.C. Wainwright第二届年度BioConnect投资者会议
马里兰州盖瑟斯堡,2024年5月13日(GLOBE NEWSWIRE)——Cartesian Therapeutics, Inc.(纳斯达克股票代码:RNAC)(“公司”)是一家开创自身免疫性疾病mRNA细胞疗法的临床阶段生物技术公司,今天
Cartesian Therapeutics Inc(RNAC)公布2024年第一季度收益:详细财务和...
凭借强劲的临床进展和战略扩张,Cartesian Therapeutics的买入评级得到确认
快讯 | HC Wainwright & Co.重申买入Cartesian Therapeutics,维持54美元的目标股价
Needham维持Cartesian Therapeutics的目标股价,为每股42.00美元
Needham维持Cartesian Therapeutics的目标股价,为每股42.00美元
快讯 | Needham重申买入Cartesian Therapeutics,维持42美元的目标股价
暂无数据
T-24Century : looking good hehe
T-24Century : they add around 12m shares and the float is now at 280m from 55m before de added shares.
Trytosaveabit楼主 T-24Century: I think they have that wrong?
T-24Century : how can you calculate the math?
the price should be maybe 38 -40?
Trytosaveabit楼主 T-24Century: That depends! Some calculate the market cap using shares in lockup and unregistered shares? Me I just use the price it’s trading at times the number of shares that are available for trading! That’s the difference between Float Market cap and Full Market Capitalization! Hope this help?
查看更多评论...